Financial Disclosure
Actualizado
Reviewed
Jun. 03, 2021
| Panel Member | Status | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Allison Agwu | M | Gilead Sciences | Advisory Board, Research Support |
| Merck & Co. | Advisory Board, Research Support, Consultant | ||
| Jason Baker | M | Gilead Sciences | Research Support |
| Curt Beckwith | M | Gilead Sciences | Research Support |
| Roger Bedimo | M | Merck & Co. | Advisory Board |
| Theratechnologies | Advisory Board | ||
| ViiV Healthcare | Advisory Board, Research Support | ||
| John T. Brooks | M | None | N/A |
| R. Douglas Bruce | M | None | N/A |
| Danielle Campbell | M | Gilead Sciences | Advisory Board |
| Geetanjali Chander | M | None | N/A |
| Laura Cheever | M | None | N/A |
| Jennifer Cocohoba | M | Genentech | Research Support |
| Janssen Pharmaceuticals | Research Support | ||
| Susan Cu-Uvin | M | None | N/A |
| Eric Daar | M | Genentech | Consultant |
| Gilead Sciences | Research Support, Consultant | ||
| Merck & Co. | Research Support, Consultant | ||
| ViiV Healthcare | Research Support | ||
| Allison Eckard | M | None | N/A |
| Rajesh Gandhi | M | None | N/A |
| Edward Gardner | M | Cepheid, Inc | Research Support |
| Gilead Sciences | Research Support | ||
| ViiV Healthcare | Research Support | ||
| Jomy George | M | None | N/A |
| Thomas Giordano | M | None | N/A |
| David Glidden | M | Gilead Sciences | Consultant |
| Merck & Co. | Advisory Board | ||
| Linda Gorgos | M | Gilead Sciences | Research Support |
| Janssen Pharmaceuticals | Research Support | ||
| Merck & Co. | Research Support | ||
| Sangamo Therapeutics | Research Support | ||
| Birgit Grund | M | None | N/A |
| Vincent Guilamo-Ramos | M | ViiV Healthcare | Advisory Board, Research Support |
| Roy M. Gulick | C | None | N/A |
| Tim Horn | M | None | N/A |
| Peter Hunt | M | Biotron Limited | Advisory Board |
| Gilead Sciences | Honoraria, Research Support | ||
| ViiV Healthcare | Consultant | ||
| Emily Hyle | M | None | N/A |
| Steven Johnson | M | ViiV Healthcare | Advisory Board |
| Rami Kantor | M | None | N/A |
| Andy Kaytes | M | None | N/A |
| Marla J. Keller | M | None | N/A |
| Arthur Kim | M | None | N/A |
| Michael Kozal | M | Gilead Sciences | Research Support |
| ViiV Healthcare | Research Support | ||
| H. Clifford Lane | C | None | N/A |
| Jeffrey Lennox | M | ViiV Healthcare | Research Support |
| Susan Little | M | None | N/A |
| Henry Masur | M | None | N/A |
| Susanna Naggie | M | AbbVie | Research Support |
| Bristol-Myers Squibb | Event Adjudication Committee | ||
| Gilead Sciences | Research Support | ||
| Vir Biotechnology | Advisory Board, Stock options | ||
| David Palm | M | None | N/A |
| Alice K. Pau | ES | None | N/A |
| Tonia Poteat | M | None | N/A |
| Asa Radix | M | None | N/A |
| James Raper | M | None | N/A |
| Daniel Reirden | M | Gilead Sciences | Research Support |
| Kimberly Scarsi | M | Merck & Co. | Research Support |
| Virginia Sheikh | M | None | N/A |
| Serena Spudich | M | None | N/A |
| Kimberly Struble | M | None | N/A |
| Susan Swindells | M | ViiV Healthcare | Research Support |
| Babafemi Taiwo | M | Gilead Sciences | Advisory Board |
| Janssen Pharmaceuticals | Advisory Board | ||
| Merck & Co. | Consultant | ||
| ViiV Healthcare | Advisor Board, Research Support | ||
| Pablo Tebas | M | Merck & Co. | Consultant |
| ViiV Healthcare | Consultant | ||
| Melanie Thompson | M | Bristol-Myers Squibb | Research Support |
| Cepheid | Research Support | ||
| CytoDyn, Inc. | Research Support | ||
| Frontier Biosciences | Research Support | ||
| Gilead Sciences | Research Support | ||
| GlaxoSmithKline | Research Support | ||
| Merck & Co. | Research Support | ||
| ViiV Healthcare | Research Support | ||
| Steven Vargas | M | ViiV Healthcare | Consultant |
| Key: C = Co-Chair; ES = Executive Secretary; M = Member | |||
Download Guidelines
- Section OnlyPDF (138.43 KB)
- Full GuidelinePDF (5.07 MB)
- Recommendations OnlyPDF (229.24 KB)
- Tables OnlyPDF (939.48 KB)